Efficacy and Safety of Mirabegron versus Placebo Add-On Therapy in Men with Overactive Bladder Symptoms Receiving Tamsulosin for Underlying Benign Prostatic Hyperplasia: A Randomized, Phase 4 Study (PLUS)
- Kaplan, S.A.
- Herschorn, S.
- McVary, K.T.
- Staskin, D.
- Chapple, C.
- Foley, S.
- Cambronero Santos, J.
- Kristy, R.M.
- Choudhury, N.
- Hairston, J.
- Schermer, C.R.
ISSN: 1527-3792
Datum der Publikation: 2020
Ausgabe: 203
Nummer: 6
Seiten: 1163-1171
Art: Artikel